ASCL2 and Lynch syndrome: Additional preclinical studies in mouse models of Lynch syndrome, such as Msh2flox/flox mouse model [55,56], will be required to determine the feasibility of using a vaccine against Ascl2 to prevent colon tumorigenesis in the setting of mismatch repair deficiency.